Table 1.
MICT (n = 17) |
HIIT (n = 19) |
|||||
---|---|---|---|---|---|---|
Sex, f/m | 12/5 |
12/7 |
||||
Age, yr | 30 ± 6 |
31 ± 7 |
||||
Height, m | 1.7 ± 0.08 |
1.71 ± 0.09 |
||||
Pretraining | Trained 1d PostEx | Trained 4d PostEx | Pretraining | Trained 1d PostEx | Trained 4d PostEx | |
Body mass, kg | 98.0 ± 11.7 | 97.3 ± 11.5 | 97.6 ± 11.7 | 96.4 ± 13.7 | 96.6 ± 13.7 | 96.6 ± 13.6 |
Fat mass, kg | 42.5 ± 7.7 | 41.8 ± 7.7* | 42.0 ± 7.7* | 40.5 ± 7.1 | 40.0 ± 7.1* | 40.1 ± 7.2* |
Fat free mass, kg | 55.5 ± 9.3 | 55.5 ± 9.5 | 55.7 ± 9.6 | 55.9 ± 10.5 | 56.5 ± 10.4 | 56.5 ± 10.3 |
BMI, kg/m2 | 34.0 ± 3.2 | 33.7 ± 3.0 | 33.8 ± 2.9 | 32.9 ± 2.9 | 32.9 ± 3.0 | 33.0 ± 3.0 |
Body fat % | 43.4 ± 6.0 | 43.1 ± 6.4* | 42.1 ± 5.4 | 41.6 ± 5.4* | ||
V̇o2peak, mL/min | 2,322 ± 544 | 2,498 ± 589* | 2,452 ± 600 | 2,750 ± 638* | ||
Plasma glucose, mM | 5.0 ± 0.4 | 4.9 ± 0.4 | 5.0 ± 0.5 | 4.8 ± 0.4 | 5.0 ± 0.4 | 4.9 ± 0.4 |
Plasma insulin, µU/mL | 18.0 ± 9.0 | 17.5 ± 6.3 | 18.8 ± 7.8 | 16.0 ± 10.0 | 15.4 ± 14.6 | 15.3 ± 7.6 |
Plasma NEFA, µM | 391 ± 159 | 440 ± 125 | 408 ± 118 | 433 ± 156 | 413 ± 123 | 387 ± 122 |
Plasma triacylglycerol, mM | 1.25 ± 0.7 | 0.99 ± 0.4 | 1.10 ± 0.6 | 0.95 ± 0.64 | 0.96 ± 0.6 | 0.91 ± 0.69 |
Data are means ± SD. *Significant main effect of training status (P < 0.05), and post hoc analysis identifying significant difference from Pretraining. BMI, body mass index; f, female; HIIT, high-intensity interval training; m, male; MICT, moderate-intensity continuous training; NEFA, nonesterified fatty acid; V̇o2peak, peak oxygen uptake rate.